Knowledge Distillery

In patients with severe coronavirus disease 2019 (COVID-19), disorders of consciousness (COVID-DoC) have emerged as a serious complication. The…

Patients hospitalised with COVID-19 are at risk for thrombotic events after discharge; the role of extended thromboprophylaxis in this population is…

Dysregulated inflammation is associated with poor outcomes in COVID-19. In this study the authors aimed to assess the efficacy of namilumab (a…

This study investigated the prevalence of long-term musculoskeletal post-COVID pain and their risk factors in a large cohort of COVID-19 survivors. A…

The COVID-19 pandemic has affected millions of individuals worldwide. The global scientific effort to design an effective vaccine against this virus…

In this paper the authors review the literature on movement disorders in the context of the COVID-19 pandemic. First, there are a variety of transient…

Since the first cases of COVID-19 were documented in Wuhan, China in 2019, the world has witnessed a devastating global pandemic, with more than 238…

In this correspondence, Zhao et al. report the first case of COVID-19 initially presenting with acute Guillain-Barré syndrome (GBS) suggesting a…

In this paper, recently published in the European Journal of Neurology, the authors reported four cases of COVID‐19‐related encephalopathy. The…

EEG Abnormalities are Common in COVID-19 and are Associated with Outcomes

The aim of this study was to estimate weather-dependent signatures in the early phase of the pandemic, while controlling for socio-economic factors…

In this brief report, Poyiadji et al. describe the first presumptive case of COVID-19–associated acute necrotizing encephalopathy (ANE) in a…